Literature DB >> 7629112

Characterization of the S3 subsite specificity of cathepsin B.

A Taralp1, H Kaplan, I I Sytwu, I Vlattas, R Bohacek, A K Knap, T Hirama, C P Huber, S Hasnain.   

Abstract

Five synthetic substrates containing different amino acid residues at the P3 position (acetyl-X-Arg-Arg-AMC, where X is Gly, Glu, Arg, Val, and Tyr and where AMC represents 7-amindo-4-methylcoumarin) were used to investigate the S3 subsite specificity of cathepsin B. At pH 6.0, the specificity constant, kcat/Km, for tripeptide substrate hydrolysis was observed to increase in the order Glu < Gly < Arg < Val < Tyr. Molecular modeling studies of substrates containing a P3 Glu, Arg, or Tyr covalently bound as the tetrahedral intermediate to the enzyme suggest that the specificity for a P3 Tyr is because of a favorable aromatic-aromatic interaction with Tyr75 on the enzyme as well as a possible H bond between the P3 Tyr hydroxyl and the side chain carboxyl of Asp69.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629112     DOI: 10.1074/jbc.270.30.18036

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.

Authors:  F C Portaro; A B Santos; M H Cezari; M A Juliano; L Juliano; E Carmona
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

3.  The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes.

Authors:  Timo Jan Oberstein; Janine Utz; Philipp Spitzer; Hans Wolfgang Klafki; Jens Wiltfang; Piotr Lewczuk; Johannes Kornhuber; Juan Manuel Maler
Journal:  Front Mol Neurosci       Date:  2021-01-12       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.